We view the stock as overvalued as expectations have become too lofty.
By Philip Gorham, CFA, FRM | 07-20-17 | 09:39 AM | Email Article

For the second consecutive quarter,  Philip Morris International  missed consensus forecasts but remains on track to meet our full-year forecasts, which remain within the lowered guidance range. We still believe the competitive advantages underpinning our wide economic moat rating are transferable to the emerging RRP portfolio, but we think expectations have become too lofty, and we view the stock as overvalued. Although we have modestly lowered our near-term estimates to reflect unfavourable currency movements, this is immaterial to our valuation, and we are reiterating our $95 fair value estimate.

Philip Gorham, CFA, FRM, is director of equity research for Ibbotson Associates Japan,subsidiary of Morningstar.

The greatest negative impact in the quarter came from currency, although on an underlying basis, volumes across the board appeared slightly soft. In Asia, in particular, volumes did not improve sequentially as we had expected, falling 9.8%, with PMI citing excise-tax-driven price increases and an increase in illicit trade as the drivers. This trickled through the income statement, and currency-neutral operating income growth slowed to 6%, down from 11% in full-year 2016.

In an environment of very sluggish consumer staples growth, this was still a decent performance, and although the company may not be meeting the market's aggressive expectations, there are several reasons not to panic. First, the U.S. dollar has weakened against the euro in recent weeks, which should provide some respite from currency headwinds in the second half of the year. Second, much of the volume shortfall appears to have been driven by the economy end of the market, which has limited impact on profitability. Third, sales of HeatSticks are picking up some of the slack. The company reported 6.3 billion in HeatStick shipments in the second quarter, up 43% sequentially from the first quarter. The impressive uptake rates iQOS has generated since last year supports our thesis that heated tobacco has a strong chance of gaining critical scale.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Securities mentioned in this article

Ticker

Price($)

Change(%)
Morningstar Rating Morningstar Analyst Report
With Morningstar Analyst reports you can get our expert Buy/Sell opinions on over 3,900 Stock and Funds
Philip Gorham, CFA, FRM does not own shares in any of the securities mentioned above. Find out about Morningstar's editorial policies.
Sponsored Links
Sponsor Center
Content Partners